Concerns & Risks -- 4/10
| Metric | ALV | Magna (MGA) | BorgWarner (BWA) | Aptiv (APTV) | Lear (LEA) |
|---|---|---|---|---|---|
| EV/EBITDA (FY26E) | ~6.4x | ~6.7x | ~10.2x | ~8.2x | ~5.4x |
| Modestly below peer average (~7.6x). Discount reflects flat organic growth and tariff overhang. | |||||
| Period | China % of Sales | Source |
|---|---|---|
| FY2024 | 19% | Daloopa src/124883651 |
| FY2025 | 19% | Daloopa src/157497761 |
| Q4 2025 | 23% | Daloopa src/155173343 |
| Catalyst | Timeline |
|---|---|
| Foldable steering wheel (Tensor/AV) | Late 2026 |
| Record new launches (Chinese OEMs) | 2026 |
| HSAE JV (safety electronics) | In motion |
| $2.5B buyback + 24% dividend hike | Active |
| Margin path to 10.5-11% (2026) then 12% medium-term | 12-24 mo |
| Risk | Detail |
|---|---|
| Tariffs | Recovered ~100% but dilutive to margin |
| USMCA Review | Single biggest risk to NA LVP |
| Antitrust Matters | Carved out of guidance |
| Hyundai Airbag Recall | Headline risk |
| China Geopolitics | ~20% exposure at risk |
Score of 4/10 reflects a business where concerns are present but well-understood and largely priced in, anchored by a durable duopoly moat, conservative leverage, and a valuation that already embeds meaningful pessimism.
Why 4 and not lower: China concentration at ~20% is far above the 10% threshold and is the single dominant risk factor. USMCA review and tariff uncertainty create unquantifiable overhangs. Antitrust matters are carved out of guidance entirely. Flat organic growth means no top-line tailwind to offset any stumble on self-help execution. Marquee AV catalysts (foldable steering wheel, zero-gravity seating) are 2030-horizon and immaterial near-term.
Why 4 and not higher: The valuation discount to peers (~6.4x vs ~7.6x EV/EBITDA) provides a meaningful cushion. Net Debt/EBITDA at 1.1x is conservative. The margin self-help bridge to 12% is quantifiable and on-track. $2.5B buyback plus a 24% dividend hike demonstrate capital return commitment. The 44% global share and growing Chinese OEM order book are structural positives. Cash generation ($734M FCF, 100% conversion) underpins downside protection.
Net assessment: The risk profile is manageable, not severe. China concentration is the binding constraint on a lower score, but the business has the balance sheet, market position, and self-help levers to absorb most downside scenarios. A 4/10 signals "monitor, don't panic."